E-LIB Suche - Ergebnisse für: Strauss, David G

1

Contractility assessment using aligned human iPSC-derived c..:

Satsuka, Ayano ; Ribeiro, Alexandre J.S. ; Kawagishi, Hiroyuki...
Journal of Pharmacological and Toxicological Methods. 128 (2024) - p. 107530 , 2024

Link: https://doi.org/10.1016/..

2

A Bioanalytical Method for Quantification of N-nitrosodimet..:

De Palma, Ryan ; Patel, Vikram ; Florian, Jeffry...
Journal of Pharmaceutical Sciences. 112 (2023) 5 - p. 1315-1323 , 2023

Link: https://doi.org/10.1016/..

3

ICH S7B In Vitro Assays Do Not Address Mechanisms of QTC Pr..:

Wu, Wendy W. ; Choe, Moran ; Johannesen, Lars...
Clinical Pharmacology & Therapeutics. 114 (2023) 6 - p. 1332-1341 , 2023

Link: https://doi.org/10.1002/..

4

New science, drug regulation, and emergent public health is..:

Chiu, Kimberly ; Racz, Rebecca ; Burkhart, Keith...
Frontiers in Medicine. 9 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Reproducibility of drug-induced effects on the contractilit..:

Arefin, Ayesha ; Mendoza, Melissa ; Dame, Keri...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Determination of five positive control drugs in hERG extern..:

King, Tamara I. ; Indapurkar, Amruta ; Tariq, Isra...
Journal of Pharmacological and Toxicological Methods. 118 (2022) - p. 107229 , 2022

Link: https://doi.org/10.1016/..

7

Pharmacodynamic Biomarkers Evidentiary Considerations for B..:

Strauss, David G. ; Wang, Yow‐Ming ; Florian, Jeffry.
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 55-61 , 2022

Link: https://doi.org/10.1002/..

8

Use of Human iPSC-CMs in Nonclinical Regulatory Studies for..:

Yang, Xi ; Ribeiro, Alexandre J S ; Pang, Li.
Toxicological Sciences. 190 (2022) 2 - p. 117-126 , 2022

Link: https://doi.org/10.1093/..

9

Evaluating the Utility of Proteomics for the Identification..:

Hyland, Paula L. ; Chekka, Lakshmi Manasa S. ; Samarth, Deepti P....
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 98-107 , 2022

Link: https://doi.org/10.1002/..

10

Advancing Innovations in Biosimilars:

Wang, Yow‐Ming ; Strauss, David G.
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 11-15 , 2022

Link: https://doi.org/10.1002/..

11

Considerations for Use of Pharmacodynamic Biomarkers to Sup..:

Sheikhy, Morasa ; Schrieber, Sarah J. ; Sun, Qin...
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 71-79 , 2022

Link: https://doi.org/10.1002/..

12

Calibration and Validation of a Mechanistic COVID‐19 Model ..:

Samieegohar, Mohammadreza ; Weaver, James L. ; Howard, Kristina E....
Clinical Pharmacology & Therapeutics. 112 (2022) 4 - p. 882-891 , 2022

Link: https://doi.org/10.1002/..

13

Considerations for Use of Pharmacodynamic Biomarkers to Sup..:

Gershuny, Victoria ; Sun, Qin ; Schrieber, Sarah J....
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 80-89 , 2022

Link: https://doi.org/10.1002/..

14

Pharmacodynamic Biomarkers for Biosimilar Development and A..:

Florian, Jeffry ; Sun, Qin ; Schrieber, Sarah J....
Clinical Pharmacology & Therapeutics. 113 (2022) 5 - p. 1030-1035 , 2022

Link: https://doi.org/10.1002/..

15

Considerations for Use of Pharmacodynamic Biomarkers to Sup..:

Florian, Jeffry ; Gershuny, Victoria ; Sun, Qin...
Clinical Pharmacology & Therapeutics. 113 (2022) 2 - p. 339-348 , 2022

Link: https://doi.org/10.1002/..